Hamzeh Rezaei

403 total citations
19 papers, 320 citations indexed

About

Hamzeh Rezaei is a scholar working on Molecular Biology, Genetics and Immunology. According to data from OpenAlex, Hamzeh Rezaei has authored 19 papers receiving a total of 320 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Genetics and 5 papers in Immunology. Recurrent topics in Hamzeh Rezaei's work include Diabetes and associated disorders (6 papers), Atherosclerosis and Cardiovascular Diseases (3 papers) and Adipokines, Inflammation, and Metabolic Diseases (3 papers). Hamzeh Rezaei is often cited by papers focused on Diabetes and associated disorders (6 papers), Atherosclerosis and Cardiovascular Diseases (3 papers) and Adipokines, Inflammation, and Metabolic Diseases (3 papers). Hamzeh Rezaei collaborates with scholars based in Iran, United Kingdom and Germany. Hamzeh Rezaei's co-authors include Mohammad Hashemi, Mohsen Taheri, Ebrahim Eskandari‐Nasab, Mahmoud Ali Kaykhaei, Aliakbar Fazaeli, Mohammad Ali Mashhadi, Seyed Mohammad Gheibi Hayat, Najma Farahani, Zahra Zakeri and Mehrdad Hajilooi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gene and Journal of Cellular Physiology.

In The Last Decade

Hamzeh Rezaei

19 papers receiving 317 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hamzeh Rezaei Iran 11 183 48 45 39 39 19 320
Toru Yanagimoto Japan 9 234 1.3× 36 0.8× 45 1.0× 72 1.8× 18 0.5× 12 408
Ailin Lu China 13 182 1.0× 51 1.1× 28 0.6× 76 1.9× 52 1.3× 20 425
Miaomiao Jia China 10 147 0.8× 43 0.9× 33 0.7× 24 0.6× 32 0.8× 32 330
Jordi Minguillón Spain 8 172 0.9× 23 0.5× 25 0.6× 46 1.2× 81 2.1× 17 371
Bok Ghee Han South Korea 13 178 1.0× 28 0.6× 93 2.1× 36 0.9× 62 1.6× 18 363
Ziyi Meng United States 6 162 0.9× 89 1.9× 21 0.5× 67 1.7× 63 1.6× 11 352
Rashmi Krishnapuram United States 9 206 1.1× 65 1.4× 100 2.2× 57 1.5× 22 0.6× 10 359
Rudolf Engelke Qatar 8 263 1.4× 86 1.8× 33 0.7× 36 0.9× 38 1.0× 15 438

Countries citing papers authored by Hamzeh Rezaei

Since Specialization
Citations

This map shows the geographic impact of Hamzeh Rezaei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hamzeh Rezaei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hamzeh Rezaei more than expected).

Fields of papers citing papers by Hamzeh Rezaei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hamzeh Rezaei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hamzeh Rezaei. The network helps show where Hamzeh Rezaei may publish in the future.

Co-authorship network of co-authors of Hamzeh Rezaei

This figure shows the co-authorship network connecting the top 25 collaborators of Hamzeh Rezaei. A scholar is included among the top collaborators of Hamzeh Rezaei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hamzeh Rezaei. Hamzeh Rezaei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
3.
Rezaei, Hamzeh, et al.. (2019). Harnessing CRISPR/Cas9 technology in cardiovascular disease. Trends in Cardiovascular Medicine. 30(2). 93–101. 16 indexed citations
4.
Solgi, Ghasem, Hamzeh Rezaei, Morteza Samadi, et al.. (2019). DECAY IN LINKAGE DISEQUILIBRIUM OF HLA HAPLOTYPE-DEFINING SNPS IN IRANIAN TYPE 1 DIABETES SUBJECTS. UWA Profiles and Research Repository (University of Western Australia). 93(5). 323–324. 1 indexed citations
5.
Farahani, Najma, et al.. (2018). CRISPR–Cas9 in genome editing: Its function and medical applications. Journal of Cellular Physiology. 234(5). 5751–5761. 35 indexed citations
6.
Eslami, Gilda, et al.. (2018). Significant Associations of the rs3104413 Single-nucleotide Polymorphism in the HLA Region with Type 1 Diabetes. 5(1). 42–48. 1 indexed citations
7.
Amirzargar, Mohammad Ali, Mona Pourjafar, Hamzeh Rezaei, et al.. (2017). Anti-inflammatory Effects of Valproic Acid in a Rat Model of Renal Ischemia/Reperfusion Injury: Alteration in Cytokine Profile. Inflammation. 40(4). 1310–1318. 31 indexed citations
8.
Solgi, Ghasem, et al.. (2016). HLA class II alleles and risk for peripheral neuropathy in type 2 diabetes patients. Neural Regeneration Research. 11(11). 1839–1839. 5 indexed citations
9.
Hajilooi, Mehrdad, et al.. (2016). Cytotoxic T Lymphocyte Antigen-4 Gene Variants in Type 2 Diabetic Patients with or without Neuropathy.. PubMed. 15(3). 220–8. 4 indexed citations
10.
Sharifi, Mohammadreza, et al.. (2016). Lack of association between rs1800795 (-174 G/C) polymorphism in the promoter region of interleukin-6 gene and susceptibility to type 2 diabetes in Isfahan population. SHILAP Revista de lepidopterología. 5(1). 18–18. 10 indexed citations
11.
Hajilooi, Mehrdad, et al.. (2015). HLA class II susceptibility pattern for type 1 diabetes (T1D) in an Iranian population. International Journal of Immunogenetics. 42(4). 279–286. 8 indexed citations
12.
Hashemi, Mohammad, Hamzeh Rezaei, Mahmoud Ali Kaykhaei, & Mohsen Taheri. (2014). A 45-bp insertion/deletion polymorphism of UCP2 gene is associated with metabolic syndrome. Journal of Diabetes & Metabolic Disorders. 13(1). 12–12. 15 indexed citations
13.
Hashemi, Mohammad, Hamzeh Rezaei, Ebrahim Eskandari‐Nasab, Mahmoud Ali Kaykhaei, & Mohsen Taheri. (2014). Association between the apelin rs2235306 gene polymorphism and metabolic syndrome. TURKISH JOURNAL OF MEDICAL SCIENCES. 44(5). 775–780. 6 indexed citations
14.
Hashemi, Mohammad, Hamzeh Rezaei, Mahmoud Ali Kaykhaei, & Mohsen Taheri. (2014). Association of the Promoter Methylation of Mitochondrial Transcription Factor A With Susceptibility to Metabolic Syndrome. Gene Cell and Tissue. 1(1). 3 indexed citations
15.
Eskandari‐Nasab, Ebrahim, Mohammad Hashemi, Hamzeh Rezaei, et al.. (2012). Evaluation of UDP-glucuronosyltransferase 2B17 (UGT2B17) and dihydrofolate reductase (DHFR) genes deletion and the expression level of NGX6 mRNA in breast cancer. Molecular Biology Reports. 39(12). 10531–10539. 31 indexed citations
16.
Hashemi, Mohammad, Ebrahim Eskandari‐Nasab, Aliakbar Fazaeli, et al.. (2012). Bi-directional PCR allele-specific amplification (bi-PASA) for detection of caspase-8 − 652 6N ins/del promoter polymorphism (rs3834129) in breast cancer. Gene. 505(1). 176–179. 36 indexed citations
17.
Hashemi, Mohammad, Hamzeh Rezaei, Ebrahim Eskandari‐Nasab, et al.. (2012). Association between chemerin rs17173608 and vaspin rs2236242 gene polymorphisms and the metabolic syndrome, a preliminary report. Gene. 510(2). 113–117. 40 indexed citations
18.
Hashemi, Mohammad, Hamzeh Rezaei, Ebrahim Eskandari‐Nasab, Mahmoud Ali Kaykhaei, & Mohsen Taheri. (2012). Association of promoter methylation and 32-bp deletion of the PTEN gene with susceptibility to metabolic syndrome. Molecular Medicine Reports. 7(1). 342–346. 19 indexed citations
19.
Hashemi, Mohammad, Ebrahim Eskandari‐Nasab, Aliakbar Fazaeli, et al.. (2012). Association Between Polymorphisms of Glutathione S- Transferase Genes ( GSTM1 , GSTP1 and GSTT1 ) and Breast Cancer Risk in a Sample Iranian Population. Biomarkers in Medicine. 6(6). 797–803. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Toru Yanagimoto Breakdown of academic impact, for papers by Ailin Lu Breakdown of academic impact, for papers by Miaomiao Jia Breakdown of academic impact, for papers by Jordi Minguillón Breakdown of academic impact, for papers by Bok Ghee Han Breakdown of academic impact, for papers by Ziyi Meng Breakdown of academic impact, for papers by Rashmi Krishnapuram Breakdown of academic impact, for papers by Rudolf Engelke
Rankless by CCL
2026